Subscribe (free)
About NaturalNews
Contact Us
Write for NaturalNews
Media Info
Advertising Info
Big Pharma

FDA Approves 18 Drugs from Pharma Company Accused of Conspiracy, Fraud

Monday, February 02, 2009 by: David Gutierrez, staff writer
Tags: Big Pharma, health news, Natural News

Most Viewed Articles
Popular on Facebook
(NaturalNews) The FDA has approved 18 products for market from generic drug manufacturer Ranbaxy Laboratories, even though the company is currently being investigated by Congress for making substandard products and conspiring to fraudulently cover it up.

"Allegations from reliable sources and supporting documents indicate a pattern of systemic fraudulent conduct, including submissions by Ranbaxy to the FDA that contain false and fabricated information," the Department of Justice said.

The Department of Justice is investigating claims that Ranbaxy, India's largest drug manufacturer, produced HIV medication that contained insufficient active ingredients or was adulterated with other ingredients. These drugs were then used to treat patients in Africa.

Other drugs are also suspected of containing active ingredients in concentrations that are either too low or too high. The company also stands accused of attempting to conceal manufacturing procedures that do not meet FDA standards and of forging documents relating to U.S. government investigations of its practices.

Finally, Ranbaxy is being investigated for falsifying data suggest that its generic drugs are absorbed into the body in a similar fashion to brand-name products. This proof is an essential part of the process of gaining FDA approval for a generic drug without going through large clinical trials.

In July, Congress also began a probe into why the FDA had not taken action against Ranbaxy, even though it had known for months of allegations against the company. As part of this probe, the FDA was asked to provide information on every FDA-approved Ranbaxy product and the approval process that it went through.

Former FDA Deputy Commissioner Mary Pendergast has criticized the FDA's failure to take action against Ranbaxy and its products.

Because the FDA "wouldn't be confident of the accuracy and reliability of the information in the applications," Pendergast said, "they might be approving a product that ought not be approved."

Sources for this story include: www.newsinferno.com.
STAY INFORMED! Free subscription to the Health Ranger's email newsletter
Get breaking news alerts on GMOs, fluoride, superfoods, natural cures and more...
Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.